New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

A first-of-its-kind drug that tackles toxic protein tangles in the brain in Alzheimer's patients could provide fresh hope to millions living with the disease. Developed by a team of international ...

The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...

A startling investigation has revealed a troubling story behind donanemab's approval -- one of questionable data, potential ...

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer's disease "hotspots" at once, in a "promising" breakthrough against the brain robbing disease. The drug - called RI ...

Some of the most valuable health advancements in 2024 related to weight loss and metabolic health. New findings about ...

Scientists have discovered a new drug that could blast toxic protein tangles in the brain that lead to Alzheimer's. The first-of-its-kind drug could provide fresh hope to millions living with ...

Whether $5 or $50, every contribution counts. Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s. Scientists have created a drug that works by targeting both ...

The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8.

Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.